Emerging Trends to Reshape the Needle-Free Drug Delivery Devices Market: Advancements In Dual Chamber Inhalers Revolutionize The Needle-Free Drug Delivery Market as a Key Influencer

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Needle-Free Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for needle-free drug delivery devices has seen a rapid surge in the recent past. The market, which was valued at $16.7 billion in 2024, is projected to rise to $18.67 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.8%. The historical growth of this market is due to factors such as the growing incidence of chronic illnesses, an increased interest in pain-free methods of drug delivery, a growing elderly population, a greater focus on patient comfort and safety, positive regulation for needle-free techniques, and growth in the pharmaceutical sector.

Needle-Free Drug Delivery Devices Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the market for needle-free drug delivery devices is predicted to experience swift expansion. It is set to reach $28.86 billion by 2029, with a compound annual growth rate (CAGR) of 11.5%. Factors contributing to this growth throughout the projected period include the heightened demand for pain-free medicine administration, an increasing focus on patient-oriented healthcare, widespread usage in pediatric and elderly patient groups, a rising incidence of chronic conditions requiring frequent injections, improvements in technology boosting device productivity and user-friendliness, greater healthcare accessibility in developing markets, and a rise in research and development investment for cutting-edge delivery mechanisms. The forecast period will witness key trends such as greater adoption of wearable devices and connectivity, the rise of innovative microfluidic technologies, a heightened emphasis on child-friendly needle-free alternatives, the introduction of artificial intelligence and machine learning computations, and broadening applications in home healthcare environments.

View the full report here:
https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

What Are the Drivers Transforming the Needle-Free Drug Delivery Devices Market?
The needle-free drug delivery device market is expected to experience rapid expansion in light of the escalating prevalence of diabetes. Diabetes, a chronic health disorder characterized by dangerously high blood sugar levels caused by inadequate insulin production or ineffective insulin utilization, is becoming increasingly widespread. Sedentary lifestyles, poor dietary practices, genetic factors, urbanization, growing elderly populations, restricted healthcare access, and the global surge in obesity rates all contribute to its rise. In managing diabetes, needle-free drug delivery devices serve as a viable substitute for traditional insulin injections. These devices employ methods like jet injectors or transdermal patches that administer insulin through the skin, foregoing the need for needles. This diminishes the stress and uneasiness frequently associated with injections, thereby increasing comfort. For example, data from the UK government's National Health Service in June 2024 revealed that the NHS identified an additional 549,000 people in England in 2023 who were at potential risk of developing type 2 diabetes. This increased the total registrants with non-diabetic hyperglycemia or pre-diabetes under a GP to 3,615,330, marking a substantial rise from 3,065,825 in 2022 - an increase of almost 20%. As such, the rising prevalence of diabetes is fueling the expansion of the needle-free drug delivery device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

What Long-Term Trends Will Define the Future of the Needle-Free Drug Delivery Devices Market?
Key players in the needle-free drug delivery device market are channeling their efforts towards innovative solutions such as dual chamber inhalers to improve effectiveness and simplify the administration process. The dual-chamber inhaler is a unique device that has two separate compartments for holding different medications. This innovative approach enables the fusion of multiple drugs into one inhaler, thus simplifying the treatment process and enhancing convenience for patients. For example, Berry Global, a plastic manufacturing company in the US, launched the BerryHaler in April 2024. This is a groundbreaking dry powder inhaler (DPI) that is designed to remodel healthcare solutions to be more patient-centered. It's a dual-chamber inhaler that integrates a dose counter to ensure accurate medication administration. Furthermore, its all-plastic construction, which lacks any metal components, makes it an ideal device for intricate inhalation treatments as it simplifies the dosage process and blends multiple drugs effectively. Its exceptional attributes comprise a bi-directional mouthpiece cover for ease and hygiene, as well as audible cues to confirm correct use. The inclusion of the dose counter helps in precise tracking of medication usage, thus reducing the chances of dosage mistakes.

Which Segments in the Needle-Free Drug Delivery Devices Market Offer the Most Profit Potential?
The needle-free drug delivery devices market covered in this report is segmented -

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types
2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications
3) By End-User: Hospitals And Clinics, Home Healthcare

Subsegments:
1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers
2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors
3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays
4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)
5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp

Which Firms Dominate the Needle-Free Drug Delivery Devices Market by Market Share and Revenue in 2025?
Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

Which Regions Offer the Highest Growth Potential in the Needle-Free Drug Delivery Devices Market?
North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.